Follow
Fernanda P. Pons-Faudoa
Fernanda P. Pons-Faudoa
Postdoctoral Fellow, Houston Methodist Research Institute
Verified email at tec.mx
Title
Cited by
Cited by
Year
Advanced implantable drug delivery technologies: transforming the clinical landscape of therapeutics for chronic diseases
FP Pons-Faudoa, A Ballerini, J Sakamoto, A Grattoni
Biomedical microdevices 21 (2), 47, 2019
1572019
2-Hydroxypropyl-β-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a nanofluidic implant for HIV pre-exposure prophylaxis
FP Pons-Faudoa, A Sizovs, N Di Trani, J Paez-Mayorga, G Bruno, ...
Journal of Controlled Release 306, 89-96, 2019
502019
Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates
FP Pons‐Faudoa, A Sizovs, KA Shelton, Z Momin, JA Niles, LR Bushman, ...
Advanced therapeutics 4 (3), 2000163, 2021
462021
Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development Meeting
JW Romano, MM Baum, ZR Demkovich, F Diana, C Dobard, PL Feldman, ...
AIDS research and human retroviruses 37 (6), 409-420, 2021
452021
Nanofluidic microsystem for sustained intraocular delivery of therapeutics
N Di Trani, P Jain, CYX Chua, JS Ho, G Bruno, A Susnjar, ...
Nanomedicine: Nanotechnology, Biology and Medicine 16, 1-9, 2019
342019
Implantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in rats
J Paez-Mayorga, JN Campa-Carranza, S Capuani, N Hernandez, HC Liu, ...
Nature communications 13 (1), 7951, 2022
222022
Effect of ultra-violet exposure on production of mycosporine-like amino acids and lipids by Lyngbya purpurem
R Chandra, FP Pons-Faudoa, RP Saldívar, BE Rittmann
Biomass and Bioenergy 134, 105475, 2020
192020
Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant
FP Pons-Faudoa, ND Trani, A Sizovs, KA Shelton, Z Momin, LR Bushman, ...
Pharmaceutics 12 (10), 981, 2020
132020
Long-acting refillable nanofluidic implant confers protection against SHIV infection in nonhuman primates
FP Pons-Faudoa, N Di Trani, S Capuani, JN Campa-Carranza, B Nehete, ...
Science Translational Medicine 15 (702), eadg2887, 2023
112023
Extending drug release from implants via transcutaneous refilling with solid therapeutics
N Di Trani, FP Pons‐Faudoa, A Sizovs, KA Shelton, MA Marzinke, ...
Advanced Therapeutics 5 (2), 2100214, 2022
112022
Trans-urocanic acid enhances tenofovir alafenamide stability for long-acting HIV applications
A Sizovs, FP Pons-Faudoa, G Malgir, KA Shelton, LR Bushman, ...
International Journal of Pharmaceutics 587, 119623, 2020
102020
Changes in local tissue microenvironment in response to subcutaneous long-acting delivery of tenofovir alafenamide in rats and non-human primates
FP Pons-Faudoa, N Di Trani, S Capuani, N Hernandez, AM Wood, ...
Journal of Controlled Release 358, 116-127, 2023
22023
Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates (Adv. Therap. 3/2021)
FP Pons‐Faudoa, A Sizovs, KA Shelton, Z Momin, JA Niles, LR Bushman, ...
Advanced Therapeutics 4 (3), 2170005, 2021
22021
Antiviral potency of long-acting islatravir subdermal implant in SHIV-infected macaques
FP Pons-Faudoa, N Di Trani, S Capuani, I Facchi, AM Wood, B Nehete, ...
Journal of Controlled Release 366, 18-27, 2024
2024
Implantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in rats.
J Paez-Mayorga, JN Campa-Carranza, S Capuani, N Hernandez, HC Liu, ...
Nature Communications 13 (1), 7951-7951, 2022
2022
Sustained release of antiretroviral therapy from nanochannel delivery implant for HIV pre-exposure prophylaxis and treatment
FP Pons Faudoa
Instituto Tecnológico y de Estudios Superiores de Monterrey, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–16